In summary, while afatinib or copanlisib alone had modest inhibitory effects on tumor growth, they did not reach statistical significance, whereas the combination of the two drugs significantly inhibited tumor growth.
← all excerpts
Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma.
1
—
—